Oxler Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Hold |
1,593
| – | – | 0.06% | 85 |
|
|
2025
Q1 | $204K | Buy |
1,593
+2
| +0.1% | +$256 | 0.07% | 84 |
|
|
2024
Q4 | $210K | Hold |
1,591
| – | – | 0.07% | 84 |
|
|
2024
Q3 | $232K | Buy |
1,591
+3
| +0.2% | +$437 | 0.08% | 81 |
|
|
2024
Q2 | $218K | Sell |
1,588
-272
| -15% | -$37.3K | 0.08% | 80 |
|
|
2024
Q1 | $255K | Buy |
1,860
+1
| +0.1% | +$137 | 0.1% | 80 |
|
|
2023
Q4 | $253K | Sell |
1,859
-3,004
| -62% | -$408K | 0.21% | 66 |
|
|
2023
Q3 | $595K | Sell |
4,863
-6
| -0.1% | -$734 | 0.3% | 63 |
|
|
2023
Q2 | $618K | Buy |
4,869
+1
| +0% | +$127 | 0.29% | 67 |
|
|
2023
Q1 | $629K | Buy |
4,868
+2
| +0% | +$258 | 0.31% | 64 |
|
|
2022
Q4 | $639K | Sell |
4,866
-247
| -5% | -$32.4K | 0.34% | 61 |
|
|
2022
Q3 | $603K | Buy |
5,113
+255
| +5% | +$30.1K | 0.34% | 65 |
|
|
2022
Q2 | $571K | Buy |
4,858
+2
| +0% | +$235 | 0.28% | 75 |
|
|
2022
Q1 | $632K | Buy |
4,856
+4
| +0.1% | +$521 | 0.29% | 76 |
|
|
2021
Q4 | $740K | Buy |
4,852
+1
| +0% | +$153 | 0.31% | 79 |
|
|
2021
Q3 | $784K | Buy |
4,851
+100
| +2% | +$16.2K | 0.35% | 77 |
|
|
2021
Q2 | $777K | Hold |
4,751
| – | – | 0.34% | 79 |
|
|
2021
Q1 | $715K | Hold |
4,751
| – | – | 0.36% | 74 |
|
|
2020
Q4 | $719K | Buy |
+4,751
| New | +$719K | 0.41% | 57 |
|